VeriMomtrigonella foenum-graecum seed extract é seguro durante a gravidez?
No EU Annex II/III listing or harmonised CLP reproductive classification was found for Trigonella foenum‑graecum seed extract (INCI). Major regulatory/assessment bodies (CosIng, ECHA C&L Inventory) show the botanical as an approved cosmetic ingredient entry but no harmonised reproductive hazard; the peer‑review literature does not identify a human teratogen or harmonised H361/H360 classification. Sources: COSING and absence of harmonised C&L; literature reviews of fenugreek note limited data and historical food/medicinal use but not a confirmed developmental hazard. (CosIng; ECHA; PubMed review).
Pregnancy-safe products containing trigonella foenum-graecum seed extract
Related ingredients
Frequently asked questions
- trigonella foenum-graecum seed extract é seguro durante a gravidez?
- No EU Annex II/III listing or harmonised CLP reproductive classification was found for Trigonella foenum‑graecum seed extract (INCI). Major regulatory/assessment bodies (CosIng, ECHA C&L Inventory) show the botanical as an approved cosmetic ingredient entry but no harmonised reproductive hazard; the peer‑review literature does not identify a human teratogen or harmonised H361/H360 classification. Sources: COSING and absence of harmonised C&L; literature reviews of fenugreek note limited data and historical food/medicinal use but not a confirmed developmental hazard. (CosIng; ECHA; PubMed review).
- trigonella foenum-graecum seed extract é seguro durante a amamentação?
- No regulatory ban or harmonised lactation hazard was identified. Clinical reviews note fenugreek has been used as an oral galactagogue and that safety data in nursing mothers/infants are limited and mixed; this is an oral systemic context, not topical cosmetic use. There is no authoritative CIR or SCCS safety opinion flagging breastfeeding risk for the cosmetic extract. (PubMed review; ECHA/COSING).
- trigonella foenum-graecum seed extract é seguro para a pele do bebê?
- No evidence of specific developmental or infant dermal toxicity was found and no regulatory restriction for use on infant skin was located. However, infant skin has higher permeability; for a botanical extract with measurable constituents, exposure via leave‑on topical use can be higher in babies — therefore exposure score is increased by +1 for 0–3 yr. No infant‑specific studies demonstrating placental/dermal transfer or endocrine disruption were found. (PubMed; COSING).
- Como o VeriMom pontua trigonella foenum-graecum seed extract?
- O VeriMom pontua trigonella foenum-graecum seed extract em 100/100 (sem riscos conhecidos) com base no status EU CosIng, classificações de perigo ECHA e estudos revisados por pares no PubMed. Nosso pipeline de pontuação é totalmente transparente.
- Quais são as alternativas seguras a trigonella foenum-graecum seed extract na gravidez?
- Veja nossa lista curada de alternativas seguras a trigonella foenum-graecum seed extract com base em função semelhante e classificação sem riscos conhecidos.
Verifique qualquer rótulo em 2 segundos
Baixe o VeriMom grátis — escaneie qualquer produto e veja a pontuação de segurança na gravidez instantaneamente.
Aviso Médico
Estas informações são apenas para fins educacionais e não constituem aconselhamento médico. As pontuações de segurança são baseadas em dados publicamente disponíveis e podem não refletir todos os riscos. Sempre consulte seu profissional de saúde antes de usar qualquer produto durante a gravidez ou amamentação.